+

WO2004020591A3 - Methodes d'utilisation de nouveaux polypeptides humains codes par des polynucleotides - Google Patents

Methodes d'utilisation de nouveaux polypeptides humains codes par des polynucleotides Download PDF

Info

Publication number
WO2004020591A3
WO2004020591A3 PCT/US2003/026864 US0326864W WO2004020591A3 WO 2004020591 A3 WO2004020591 A3 WO 2004020591A3 US 0326864 W US0326864 W US 0326864W WO 2004020591 A3 WO2004020591 A3 WO 2004020591A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
polynucleotides
modulators
polypeptides encoded
compositions
Prior art date
Application number
PCT/US2003/026864
Other languages
English (en)
Other versions
WO2004020591A2 (fr
Inventor
Lewis T Williams
Keting Chu
Ernestine Lee
Kevin Hestir
Pierre Alvaro Beaurang
Dirk Behrens
Robert Forgan Halenbeck
Min Mei Huang
Srinivas Kothakota
Lin Haishan
Thomas Linnemann
Kristen Pierce
Yan Wang
Justin G P Wong
Ge Wu
Hongbing Zhang
Original Assignee
Five Prime Therapeutics Inc
Lewis T Williams
Keting Chu
Ernestine Lee
Kevin Hestir
Pierre Alvaro Beaurang
Dirk Behrens
Robert Forgan Halenbeck
Min Mei Huang
Srinivas Kothakota
Lin Haishan
Thomas Linnemann
Kristen Pierce
Yan Wang
Justin G P Wong
Ge Wu
Hongbing Zhang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Five Prime Therapeutics Inc, Lewis T Williams, Keting Chu, Ernestine Lee, Kevin Hestir, Pierre Alvaro Beaurang, Dirk Behrens, Robert Forgan Halenbeck, Min Mei Huang, Srinivas Kothakota, Lin Haishan, Thomas Linnemann, Kristen Pierce, Yan Wang, Justin G P Wong, Ge Wu, Hongbing Zhang filed Critical Five Prime Therapeutics Inc
Priority to AU2003265787A priority Critical patent/AU2003265787A1/en
Publication of WO2004020591A2 publication Critical patent/WO2004020591A2/fr
Publication of WO2004020591A3 publication Critical patent/WO2004020591A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne de nouveaux polynucléotides, des polypeptides associés, des compositions d'acides nucléiques et de polypeptides associées et des modulateurs associés, tels que des anticorps et des modulateurs de petites molécules. L'invention concerne également des méthodes permettant de fabriquer et d'utiliser ces polynucléotides, ces polypeptides, ces compositions associées et ces modulateurs. Ces méthodes sont destinées à des applications diagnostiques, prophylactiques et thérapeutiques. Les compositions et les méthodes selon l'invention sont utiles pour le traitement de troubles prolifératifs, par exemple, les cancers et les troubles inflammatoires, immunitaires, bactériens et viraux.
PCT/US2003/026864 2002-08-29 2003-08-28 Methodes d'utilisation de nouveaux polypeptides humains codes par des polynucleotides WO2004020591A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003265787A AU2003265787A1 (en) 2002-08-29 2003-08-28 Methods of use for novel human polypeptides encoded by polynucleotides

Applications Claiming Priority (68)

Application Number Priority Date Filing Date Title
US40664602P 2002-08-29 2002-08-29
US40665302P 2002-08-29 2002-08-29
US40658802P 2002-08-29 2002-08-29
US40660802P 2002-08-29 2002-08-29
US40657902P 2002-08-29 2002-08-29
US40658502P 2002-08-29 2002-08-29
US40664202P 2002-08-29 2002-08-29
US60/406,588 2002-08-29
US60/406,585 2002-08-29
US60/406,653 2002-08-29
US60/406,646 2002-08-29
US60/406,642 2002-08-29
US60/406,608 2002-08-29
US60/406,579 2002-08-29
US41105502P 2002-09-17 2002-09-17
US41104102P 2002-09-17 2002-09-17
US41103502P 2002-09-17 2002-09-17
US41104502P 2002-09-17 2002-09-17
US41110102P 2002-09-17 2002-09-17
US41094902P 2002-09-17 2002-09-17
US41096102P 2002-09-17 2002-09-17
US41095802P 2002-09-17 2002-09-17
US41102302P 2002-09-17 2002-09-17
US41095902P 2002-09-17 2002-09-17
US41094802P 2002-09-17 2002-09-17
US41094702P 2002-09-17 2002-09-17
US41104802P 2002-09-17 2002-09-17
US41107302P 2002-09-17 2002-09-17
US60/410,958 2002-09-17
US60/411,073 2002-09-17
US60/411,045 2002-09-17
US60/411,041 2002-09-17
US60/410,947 2002-09-17
US60/411,101 2002-09-17
US60/411,055 2002-09-17
US60/411,035 2002-09-17
US60/410,961 2002-09-17
US60/411,023 2002-09-17
US60/410,949 2002-09-17
US60/410,948 2002-09-17
US60/410,959 2002-09-17
US60/411,048 2002-09-17
US46371603P 2003-04-18 2003-04-18
US46370803P 2003-04-18 2003-04-18
US60/463,708 2003-04-18
US60/463,716 2003-04-18
US46720103P 2003-05-02 2003-05-02
US46719903P 2003-05-02 2003-05-02
US60/467,199 2003-05-02
US60/467,201 2003-05-02
US47133603P 2003-05-19 2003-05-19
US60/471,336 2003-05-19
US47243003P 2003-05-22 2003-05-22
US60/472,430 2003-05-22
US47664103P 2003-06-09 2003-06-09
US60/476,641 2003-06-09
US48521803P 2003-07-08 2003-07-08
US48522403P 2003-07-08 2003-07-08
US60/485,218 2003-07-08
US60/485,224 2003-07-08
US48644603P 2003-07-14 2003-07-14
US60/486,446 2003-07-14
US48689103P 2003-07-15 2003-07-15
US60/486,891 2003-07-15
US49334103P 2003-08-08 2003-08-08
US49357703P 2003-08-08 2003-08-08
US60/493,577 2003-08-08
US60/493,341 2003-08-08

Publications (2)

Publication Number Publication Date
WO2004020591A2 WO2004020591A2 (fr) 2004-03-11
WO2004020591A3 true WO2004020591A3 (fr) 2005-03-24

Family

ID=34317894

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/026864 WO2004020591A2 (fr) 2002-08-29 2003-08-28 Methodes d'utilisation de nouveaux polypeptides humains codes par des polynucleotides

Country Status (2)

Country Link
AU (1) AU2003265787A1 (fr)
WO (1) WO2004020591A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8981061B2 (en) 2001-03-20 2015-03-17 Novo Nordisk A/S Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
GB0426146D0 (en) 2004-11-29 2004-12-29 Bioxell Spa Therapeutic peptides and method
RS57827B1 (sr) 2012-02-15 2018-12-31 Novo Nordisk As Antitela koja vezuju protein 1 prepoznavanja peptidoglikana
US9550830B2 (en) 2012-02-15 2017-01-24 Novo Nordisk A/S Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
PL2814844T3 (pl) 2012-02-15 2017-12-29 Novo Nordisk A/S Przeciwciała wiążące i blokujące receptor aktywujący wykazujący ekspresję na komórkach szpikowych -1 (trem-1)
KR102641268B1 (ko) 2014-07-17 2024-02-27 노보 노르디스크 에이/에스 점도를 감소시키기 위한 trem-1 항체의 부위 지정 돌연변이유발
JOP20200240A1 (ar) 2018-04-02 2020-09-27 Bristol Myers Squibb Co أجسام مضادة ضد- trem-1 واستخداماتها

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010025098A1 (en) * 1998-03-13 2001-09-27 Incyte Pharmaceuticals, Inc. Human membrane-spanning proteins
US6555654B1 (en) * 1997-04-15 2003-04-29 The Wellcome Trust Limited As Trustee For The Wellcome Trust LDL-receptor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555654B1 (en) * 1997-04-15 2003-04-29 The Wellcome Trust Limited As Trustee For The Wellcome Trust LDL-receptor
US20010025098A1 (en) * 1998-03-13 2001-09-27 Incyte Pharmaceuticals, Inc. Human membrane-spanning proteins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BROWN ET AL.: "Isolation and characterization of LRP6, a novel member of the low density lipoprotein receptor gene family", BIOCHEMICAL AND BIPHYSICAL RESEARCH COMMUNICATIONS, vol. 248, no. 3, July 1998 (1998-07-01), pages 879 - 888, XP002249367 *

Also Published As

Publication number Publication date
AU2003265787A1 (en) 2004-03-19
WO2004020591A2 (fr) 2004-03-11
AU2003265787A8 (en) 2004-03-19

Similar Documents

Publication Publication Date Title
WO2004035732A3 (fr) Polypeptides humains codes par des polynucleotides et procedes d'utilisation de ces polypeptides
WO2004020595A3 (fr) Nouveaux polypeptides humains codes par des polynucleotides
WO2004000997A3 (fr) Polypeptides therapeutiques, acides nucleiques les codant et principes d'utilisation
WO2004093804A3 (fr) Polypeptides humains codes par des polynucleotides et methodes d'utilisation associees
WO2002055705A3 (fr) Proteines et acides nucleiques codant ces proteines
WO2003033658A3 (fr) Neutrokine-alpha et variant d'epissage de neutrokine-alpha
WO2002068649A3 (fr) Proteines et acides nucleiques les codant
WO2004094651A3 (fr) Nouveaux polypeptides humains codes par des polynucleotides
WO2004099388A3 (fr) Complexes de polypeptides cbl-b et methodes associees
WO2001090155A3 (fr) Nouvelles proteines et acides nucleiques codant pour ces proteines
WO2002068652A3 (fr) Proteines et acides nucleiques codant ces proteines
WO2004020591A3 (fr) Methodes d'utilisation de nouveaux polypeptides humains codes par des polynucleotides
WO2004038003A3 (fr) Polypeptides humains codes par des polynucleotides et methodes d'utilisation
NZ524329A (en) IgE receptor antagonists that compete with IgE134 for binding to the receptor
WO2002055704A3 (fr) Proteines, polynucleotides codant pour elles et procedes d'utilisation correspondants
IL207012A0 (en) Diagnosis and therapy of cancer using sgp28-related molecules
WO2003029423A3 (fr) Polypeptides therapeutiques, acides nucleiques codant ceux-ci et procedes d'utilisation
WO2005085280A3 (fr) Clones d'adnc humains comportant des polynucleotides et leurs procedes d'utilisation
WO2004039952A3 (fr) Procedes d'utilisation de polypeptides humains codes par des polynucleotides
WO2003022998A3 (fr) Polypeptides therapeutiques, acides nucleiques codant ces derniers et methodes d'utilisation correspondantes
WO2003078572A3 (fr) Polypeptides therapeutiques, acides nucleiques codant pour ceux-ci et procedes d'utilisation
WO2003031571A3 (fr) Nouvelles proteines humaines, polynucleotides les codant et methodes d'utilisation afferentes
WO2004046310A3 (fr) Nouveaux polypeptides de souris codes par des polynucleotides et leurs procedes d'utilisation
WO2003040329A3 (fr) Polypeptides therapeutiques, acides nucleiques les codant et procedes d'utilisation correspondant
WO2004094598A3 (fr) Procedes d'utilisation pour de nouveaux polypeptides humains codes par des polynucleotides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载